Global Intravenous Immunoglobulin (IVIg) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Page: 120

Published Date: 08 Jan 2025

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 11890 million in 2024 and is forecast to a readjusted size of USD 17520 million by 2031 with a CAGR of 5.8% during review period.

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.

This report is a detailed and comprehensive analysis for global Intravenous Immunoglobulin (IVIg) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Intravenous Immunoglobulin (IVIg) market size and forecasts, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2020-2031
Global Intravenous Immunoglobulin (IVIg) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2020-2031
Global Intravenous Immunoglobulin (IVIg) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2020-2031
Global Intravenous Immunoglobulin (IVIg) market shares of main players, shipments in revenue ($ Million), sales quantity (K Bottle), and ASP (USD/Bottle), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intravenous Immunoglobulin (IVIg)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intravenous Immunoglobulin (IVIg) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Intravenous Immunoglobulin (IVIg) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    IVIg Liquid
    IVIg Powder

Market segment by Application
    Immunodeficiency
    Autoimmune Disease
    Acute Infection

Major players covered
    Baxter
    Grifols
    CSL
    Octapharma
    Biotest
    Kedrion
    Hualan Bio
    CNBG
    Shanghai RAAS
    CBPO
    LFB Group
    BPL
    Sichuan Yuanda Shuyang

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Immunoglobulin (IVIg) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravenous Immunoglobulin (IVIg), with price, sales quantity, revenue, and global market share of Intravenous Immunoglobulin (IVIg) from 2020 to 2025.
Chapter 3, the Intravenous Immunoglobulin (IVIg) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Immunoglobulin (IVIg) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Intravenous Immunoglobulin (IVIg) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous Immunoglobulin (IVIg).
Chapter 14 and 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Intravenous Immunoglobulin (IVIg) Consumption Value by Type: 2020 Versus 2024 Versus 2031
        1.3.2 IVIg Liquid
        1.3.3 IVIg Powder
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Intravenous Immunoglobulin (IVIg) Consumption Value by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Immunodeficiency
        1.4.3 Autoimmune Disease
        1.4.4 Acute Infection
    1.5 Global Intravenous Immunoglobulin (IVIg) Market Size & Forecast
        1.5.1 Global Intravenous Immunoglobulin (IVIg) Consumption Value (2020 & 2024 & 2031)
        1.5.2 Global Intravenous Immunoglobulin (IVIg) Sales Quantity (2020-2031)
        1.5.3 Global Intravenous Immunoglobulin (IVIg) Average Price (2020-2031)

2 Manufacturers Profiles
    2.1 Baxter
        2.1.1 Baxter Details
        2.1.2 Baxter Major Business
        2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Product and Services
        2.1.4 Baxter Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Baxter Recent Developments/Updates
    2.2 Grifols
        2.2.1 Grifols Details
        2.2.2 Grifols Major Business
        2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Product and Services
        2.2.4 Grifols Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Grifols Recent Developments/Updates
    2.3 CSL
        2.3.1 CSL Details
        2.3.2 CSL Major Business
        2.3.3 CSL Intravenous Immunoglobulin (IVIg) Product and Services
        2.3.4 CSL Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 CSL Recent Developments/Updates
    2.4 Octapharma
        2.4.1 Octapharma Details
        2.4.2 Octapharma Major Business
        2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Product and Services
        2.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Octapharma Recent Developments/Updates
    2.5 Biotest
        2.5.1 Biotest Details
        2.5.2 Biotest Major Business
        2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Product and Services
        2.5.4 Biotest Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Biotest Recent Developments/Updates
    2.6 Kedrion
        2.6.1 Kedrion Details
        2.6.2 Kedrion Major Business
        2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Product and Services
        2.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 Kedrion Recent Developments/Updates
    2.7 Hualan Bio
        2.7.1 Hualan Bio Details
        2.7.2 Hualan Bio Major Business
        2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Product and Services
        2.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Hualan Bio Recent Developments/Updates
    2.8 CNBG
        2.8.1 CNBG Details
        2.8.2 CNBG Major Business
        2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Product and Services
        2.8.4 CNBG Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 CNBG Recent Developments/Updates
    2.9 Shanghai RAAS
        2.9.1 Shanghai RAAS Details
        2.9.2 Shanghai RAAS Major Business
        2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product and Services
        2.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Shanghai RAAS Recent Developments/Updates
    2.10 CBPO
        2.10.1 CBPO Details
        2.10.2 CBPO Major Business
        2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Product and Services
        2.10.4 CBPO Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 CBPO Recent Developments/Updates
    2.11 LFB Group
        2.11.1 LFB Group Details
        2.11.2 LFB Group Major Business
        2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Product and Services
        2.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 LFB Group Recent Developments/Updates
    2.12 BPL
        2.12.1 BPL Details
        2.12.2 BPL Major Business
        2.12.3 BPL Intravenous Immunoglobulin (IVIg) Product and Services
        2.12.4 BPL Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 BPL Recent Developments/Updates
    2.13 Sichuan Yuanda Shuyang
        2.13.1 Sichuan Yuanda Shuyang Details
        2.13.2 Sichuan Yuanda Shuyang Major Business
        2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product and Services
        2.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates

3 Competitive Environment: Intravenous Immunoglobulin (IVIg) by Manufacturer
    3.1 Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Manufacturer (2020-2025)
    3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2020-2025)
    3.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturer (2020-2025)
    3.4 Market Share Analysis (2024)
        3.4.1 Producer Shipments of Intravenous Immunoglobulin (IVIg) by Manufacturer Revenue ($MM) and Market Share (%): 2024
        3.4.2 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2024
        3.4.3 Top 6 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2024
    3.5 Intravenous Immunoglobulin (IVIg) Market: Overall Company Footprint Analysis
        3.5.1 Intravenous Immunoglobulin (IVIg) Market: Region Footprint
        3.5.2 Intravenous Immunoglobulin (IVIg) Market: Company Product Type Footprint
        3.5.3 Intravenous Immunoglobulin (IVIg) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region
        4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Region (2020-2031)
        4.1.2 Global Intravenous Immunoglobulin (IVIg) Consumption Value by Region (2020-2031)
        4.1.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Region (2020-2031)
    4.2 North America Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)
    4.3 Europe Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)
    4.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)
    4.5 South America Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)
    4.6 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)

5 Market Segment by Type
    5.1 Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
    5.2 Global Intravenous Immunoglobulin (IVIg) Consumption Value by Type (2020-2031)
    5.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Type (2020-2031)

6 Market Segment by Application
    6.1 Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
    6.2 Global Intravenous Immunoglobulin (IVIg) Consumption Value by Application (2020-2031)
    6.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Application (2020-2031)

7 North America
    7.1 North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
    7.2 North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
    7.3 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
        7.3.1 North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2031)
        7.3.2 North America Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2031)
        7.3.3 United States Market Size and Forecast (2020-2031)
        7.3.4 Canada Market Size and Forecast (2020-2031)
        7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe
    8.1 Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
    8.2 Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
    8.3 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
        8.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2031)
        8.3.2 Europe Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2031)
        8.3.3 Germany Market Size and Forecast (2020-2031)
        8.3.4 France Market Size and Forecast (2020-2031)
        8.3.5 United Kingdom Market Size and Forecast (2020-2031)
        8.3.6 Russia Market Size and Forecast (2020-2031)
        8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific
    9.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
    9.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
    9.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Region
        9.3.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Region (2020-2031)
        9.3.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Value by Region (2020-2031)
        9.3.3 China Market Size and Forecast (2020-2031)
        9.3.4 Japan Market Size and Forecast (2020-2031)
        9.3.5 South Korea Market Size and Forecast (2020-2031)
        9.3.6 India Market Size and Forecast (2020-2031)
        9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
        9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America
    10.1 South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
    10.2 South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
    10.3 South America Intravenous Immunoglobulin (IVIg) Market Size by Country
        10.3.1 South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2031)
        10.3.2 South America Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2031)
        10.3.3 Brazil Market Size and Forecast (2020-2031)
        10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa
    11.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
    11.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
    11.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) Market Size by Country
        11.3.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2031)
        11.3.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2031)
        11.3.3 Turkey Market Size and Forecast (2020-2031)
        11.3.4 Egypt Market Size and Forecast (2020-2031)
        11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
        11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics
    12.1 Intravenous Immunoglobulin (IVIg) Market Drivers
    12.2 Intravenous Immunoglobulin (IVIg) Market Restraints
    12.3 Intravenous Immunoglobulin (IVIg) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Intravenous Immunoglobulin (IVIg) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Intravenous Immunoglobulin (IVIg)
    13.3 Intravenous Immunoglobulin (IVIg) Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Intravenous Immunoglobulin (IVIg) Typical Distributors
    14.3 Intravenous Immunoglobulin (IVIg) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Baxter Basic Information, Manufacturing Base and Competitors
 Table 4. Baxter Major Business
 Table 5. Baxter Intravenous Immunoglobulin (IVIg) Product and Services
 Table 6. Baxter Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 7. Baxter Recent Developments/Updates
 Table 8. Grifols Basic Information, Manufacturing Base and Competitors
 Table 9. Grifols Major Business
 Table 10. Grifols Intravenous Immunoglobulin (IVIg) Product and Services
 Table 11. Grifols Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 12. Grifols Recent Developments/Updates
 Table 13. CSL Basic Information, Manufacturing Base and Competitors
 Table 14. CSL Major Business
 Table 15. CSL Intravenous Immunoglobulin (IVIg) Product and Services
 Table 16. CSL Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 17. CSL Recent Developments/Updates
 Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
 Table 19. Octapharma Major Business
 Table 20. Octapharma Intravenous Immunoglobulin (IVIg) Product and Services
 Table 21. Octapharma Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 22. Octapharma Recent Developments/Updates
 Table 23. Biotest Basic Information, Manufacturing Base and Competitors
 Table 24. Biotest Major Business
 Table 25. Biotest Intravenous Immunoglobulin (IVIg) Product and Services
 Table 26. Biotest Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 27. Biotest Recent Developments/Updates
 Table 28. Kedrion Basic Information, Manufacturing Base and Competitors
 Table 29. Kedrion Major Business
 Table 30. Kedrion Intravenous Immunoglobulin (IVIg) Product and Services
 Table 31. Kedrion Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 32. Kedrion Recent Developments/Updates
 Table 33. Hualan Bio Basic Information, Manufacturing Base and Competitors
 Table 34. Hualan Bio Major Business
 Table 35. Hualan Bio Intravenous Immunoglobulin (IVIg) Product and Services
 Table 36. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 37. Hualan Bio Recent Developments/Updates
 Table 38. CNBG Basic Information, Manufacturing Base and Competitors
 Table 39. CNBG Major Business
 Table 40. CNBG Intravenous Immunoglobulin (IVIg) Product and Services
 Table 41. CNBG Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 42. CNBG Recent Developments/Updates
 Table 43. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
 Table 44. Shanghai RAAS Major Business
 Table 45. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product and Services
 Table 46. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 47. Shanghai RAAS Recent Developments/Updates
 Table 48. CBPO Basic Information, Manufacturing Base and Competitors
 Table 49. CBPO Major Business
 Table 50. CBPO Intravenous Immunoglobulin (IVIg) Product and Services
 Table 51. CBPO Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 52. CBPO Recent Developments/Updates
 Table 53. LFB Group Basic Information, Manufacturing Base and Competitors
 Table 54. LFB Group Major Business
 Table 55. LFB Group Intravenous Immunoglobulin (IVIg) Product and Services
 Table 56. LFB Group Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 57. LFB Group Recent Developments/Updates
 Table 58. BPL Basic Information, Manufacturing Base and Competitors
 Table 59. BPL Major Business
 Table 60. BPL Intravenous Immunoglobulin (IVIg) Product and Services
 Table 61. BPL Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 62. BPL Recent Developments/Updates
 Table 63. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
 Table 64. Sichuan Yuanda Shuyang Major Business
 Table 65. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product and Services
 Table 66. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales Quantity (K Bottle), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 67. Sichuan Yuanda Shuyang Recent Developments/Updates
 Table 68. Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Manufacturer (2020-2025) & (K Bottle)
 Table 69. Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2020-2025) & (USD Million)
 Table 70. Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturer (2020-2025) & (USD/Bottle)
 Table 71. Market Position of Manufacturers in Intravenous Immunoglobulin (IVIg), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 72. Head Office and Intravenous Immunoglobulin (IVIg) Production Site of Key Manufacturer
 Table 73. Intravenous Immunoglobulin (IVIg) Market: Company Product Type Footprint
 Table 74. Intravenous Immunoglobulin (IVIg) Market: Company Product Application Footprint
 Table 75. Intravenous Immunoglobulin (IVIg) New Market Entrants and Barriers to Market Entry
 Table 76. Intravenous Immunoglobulin (IVIg) Mergers, Acquisition, Agreements, and Collaborations
 Table 77. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
 Table 78. Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Region (2020-2025) & (K Bottle)
 Table 79. Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Region (2026-2031) & (K Bottle)
 Table 80. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Region (2020-2025) & (USD Million)
 Table 81. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Region (2026-2031) & (USD Million)
 Table 82. Global Intravenous Immunoglobulin (IVIg) Average Price by Region (2020-2025) & (USD/Bottle)
 Table 83. Global Intravenous Immunoglobulin (IVIg) Average Price by Region (2026-2031) & (USD/Bottle)
 Table 84. Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2025) & (K Bottle)
 Table 85. Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2026-2031) & (K Bottle)
 Table 86. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Type (2020-2025) & (USD Million)
 Table 87. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Type (2026-2031) & (USD Million)
 Table 88. Global Intravenous Immunoglobulin (IVIg) Average Price by Type (2020-2025) & (USD/Bottle)
 Table 89. Global Intravenous Immunoglobulin (IVIg) Average Price by Type (2026-2031) & (USD/Bottle)
 Table 90. Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2025) & (K Bottle)
 Table 91. Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2026-2031) & (K Bottle)
 Table 92. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Application (2020-2025) & (USD Million)
 Table 93. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Application (2026-2031) & (USD Million)
 Table 94. Global Intravenous Immunoglobulin (IVIg) Average Price by Application (2020-2025) & (USD/Bottle)
 Table 95. Global Intravenous Immunoglobulin (IVIg) Average Price by Application (2026-2031) & (USD/Bottle)
 Table 96. North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2025) & (K Bottle)
 Table 97. North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2026-2031) & (K Bottle)
 Table 98. North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2025) & (K Bottle)
 Table 99. North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2026-2031) & (K Bottle)
 Table 100. North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2025) & (K Bottle)
 Table 101. North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2026-2031) & (K Bottle)
 Table 102. North America Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2025) & (USD Million)
 Table 103. North America Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2026-2031) & (USD Million)
 Table 104. Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2025) & (K Bottle)
 Table 105. Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2026-2031) & (K Bottle)
 Table 106. Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2025) & (K Bottle)
 Table 107. Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2026-2031) & (K Bottle)
 Table 108. Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2025) & (K Bottle)
 Table 109. Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2026-2031) & (K Bottle)
 Table 110. Europe Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2025) & (USD Million)
 Table 111. Europe Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2026-2031) & (USD Million)
 Table 112. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2025) & (K Bottle)
 Table 113. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2026-2031) & (K Bottle)
 Table 114. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2025) & (K Bottle)
 Table 115. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2026-2031) & (K Bottle)
 Table 116. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Region (2020-2025) & (K Bottle)
 Table 117. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Region (2026-2031) & (K Bottle)
 Table 118. Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Value by Region (2020-2025) & (USD Million)
 Table 119. Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Value by Region (2026-2031) & (USD Million)
 Table 120. South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2025) & (K Bottle)
 Table 121. South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2026-2031) & (K Bottle)
 Table 122. South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2025) & (K Bottle)
 Table 123. South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2026-2031) & (K Bottle)
 Table 124. South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2025) & (K Bottle)
 Table 125. South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2026-2031) & (K Bottle)
 Table 126. South America Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2025) & (USD Million)
 Table 127. South America Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2026-2031) & (USD Million)
 Table 128. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2025) & (K Bottle)
 Table 129. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2026-2031) & (K Bottle)
 Table 130. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2025) & (K Bottle)
 Table 131. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2026-2031) & (K Bottle)
 Table 132. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2025) & (K Bottle)
 Table 133. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2026-2031) & (K Bottle)
 Table 134. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2025) & (USD Million)
 Table 135. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2026-2031) & (USD Million)
 Table 136. Intravenous Immunoglobulin (IVIg) Raw Material
 Table 137. Key Manufacturers of Intravenous Immunoglobulin (IVIg) Raw Materials
 Table 138. Intravenous Immunoglobulin (IVIg) Typical Distributors
 Table 139. Intravenous Immunoglobulin (IVIg) Typical Customers


List of Figures
 Figure 1. Intravenous Immunoglobulin (IVIg) Picture
 Figure 2. Global Intravenous Immunoglobulin (IVIg) Revenue by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type in 2024
 Figure 4. IVIg Liquid Examples
 Figure 5. IVIg Powder Examples
 Figure 6. Global Intravenous Immunoglobulin (IVIg) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 7. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application in 2024
 Figure 8. Immunodeficiency Examples
 Figure 9. Autoimmune Disease Examples
 Figure 10. Acute Infection Examples
 Figure 11. Global Intravenous Immunoglobulin (IVIg) Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 12. Global Intravenous Immunoglobulin (IVIg) Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales Quantity (2020-2031) & (K Bottle)
 Figure 14. Global Intravenous Immunoglobulin (IVIg) Price (2020-2031) & (USD/Bottle)
 Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Manufacturer in 2024
 Figure 16. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2024
 Figure 17. Producer Shipments of Intravenous Immunoglobulin (IVIg) by Manufacturer Sales ($MM) and Market Share (%): 2024
 Figure 18. Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer (Revenue) Market Share in 2024
 Figure 19. Top 6 Intravenous Immunoglobulin (IVIg) Manufacturer (Revenue) Market Share in 2024
 Figure 20. Global Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Region (2020-2031)
 Figure 21. Global Intravenous Immunoglobulin (IVIg) Consumption Value Market Share by Region (2020-2031)
 Figure 22. North America Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 23. Europe Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 24. Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 25. South America Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 26. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 27. Global Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Type (2020-2031)
 Figure 28. Global Intravenous Immunoglobulin (IVIg) Consumption Value Market Share by Type (2020-2031)
 Figure 29. Global Intravenous Immunoglobulin (IVIg) Average Price by Type (2020-2031) & (USD/Bottle)
 Figure 30. Global Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Application (2020-2031)
 Figure 31. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2020-2031)
 Figure 32. Global Intravenous Immunoglobulin (IVIg) Average Price by Application (2020-2031) & (USD/Bottle)
 Figure 33. North America Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Type (2020-2031)
 Figure 34. North America Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Application (2020-2031)
 Figure 35. North America Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Country (2020-2031)
 Figure 36. North America Intravenous Immunoglobulin (IVIg) Consumption Value Market Share by Country (2020-2031)
 Figure 37. United States Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 38. Canada Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 39. Mexico Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 40. Europe Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Type (2020-2031)
 Figure 41. Europe Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Application (2020-2031)
 Figure 42. Europe Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Country (2020-2031)
 Figure 43. Europe Intravenous Immunoglobulin (IVIg) Consumption Value Market Share by Country (2020-2031)
 Figure 44. Germany Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 45. France Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 46. United Kingdom Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 47. Russia Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 48. Italy Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 49. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Type (2020-2031)
 Figure 50. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Application (2020-2031)
 Figure 51. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Region (2020-2031)
 Figure 52. Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Value Market Share by Region (2020-2031)
 Figure 53. China Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 54. Japan Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 55. South Korea Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 56. India Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 57. Southeast Asia Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 58. Australia Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 59. South America Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Type (2020-2031)
 Figure 60. South America Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Application (2020-2031)
 Figure 61. South America Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Country (2020-2031)
 Figure 62. South America Intravenous Immunoglobulin (IVIg) Consumption Value Market Share by Country (2020-2031)
 Figure 63. Brazil Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 64. Argentina Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 65. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Type (2020-2031)
 Figure 66. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Application (2020-2031)
 Figure 67. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity Market Share by Country (2020-2031)
 Figure 68. Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Value Market Share by Country (2020-2031)
 Figure 69. Turkey Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 70. Egypt Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 71. Saudi Arabia Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 72. South Africa Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031) & (USD Million)
 Figure 73. Intravenous Immunoglobulin (IVIg) Market Drivers
 Figure 74. Intravenous Immunoglobulin (IVIg) Market Restraints
 Figure 75. Intravenous Immunoglobulin (IVIg) Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin (IVIg) in 2024
 Figure 78. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
 Figure 79. Intravenous Immunoglobulin (IVIg) Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

Related Reports

Global Intravenous Immunoglobulin (IVIg) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Intravenous Immunoglobulin (IVIg) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Global Intravenous Immunoglobulin (IVIg) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Intravenous Immunoglobulin (IVIg) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at USD 10610 million in 2023 and is forecast to a readjusted size of USD 15580 million by 2030 with a CAGR of 5.6% during review period.

Global Intravenous Immunoglobulin (IVIg) Supply, Demand and Key Producers, 2024-2030

Global Intravenous Immunoglobulin (IVIg) Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Intravenous Immunoglobulin (IVIg) market size is expected to reach $ 15580 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

Product Tags

Intravenous Immunoglobulin (IVIg)

Intravenous Immunoglobulin(IVIg) Therapy

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>